Letermovir for Cytomegalovirus Prophylaxis in Pediatric Kidney Transplant Recipients with Valganciclovir-Associated Leukopenia (KIDNEY WEEK 2025) - Oct 18, 2025 - Abstract #SA-PO0687; Pres time: Nov 8, 2025; 10:00 AM - 12:00 PM; Location: Exhibit Hall, Convention Center; "Filgrastim was administered to all patients, potentially influencing WBC count. Prospective studies are needed to confirm these findings. DDKT: deceased donor kidney transplant ATG: antithymocyte globulin"
Clinical • Cytomegalovirus Infection • Hematological Disorders • Leukopenia • Pediatrics • Transplantation
|
|
Saritha Ranabothu; Laura Blake
|